Sign In
Buy AMPH
$19.94
-0.440 (-2.16%)
At Close: Jul 31, 2026
Why Amphastar Pharmaceuticals Is A Strong Buy: Growth, Valuation, And Strategic Acquisitions
01:37pm, Monday, 04'th Mar 2024
Amphastar Pharmaceuticals specializes in developing, manufacturing, and distributing pharmaceutical products, with a focus on strategic acquisitions. The company's portfolio includes high-margin produ
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2023 Earnings Call Transcript
07:46pm, Thursday, 29'th Feb 2024
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2023 Earnings Call Transcript
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
06:26pm, Wednesday, 28'th Feb 2024
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.73 per share a year ago.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
04:05pm, Wednesday, 28'th Feb 2024
Reports Net Revenues of $178.1 Million for the Three Months Ended December 31, 2023 RANCHO CUCAMONGA, CA / ACCESSWIRE / February 28, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" o
Amphastar Pharmaceuticals (AMPH) Increases Yet Falls Behind Market: What Investors Need to Know
06:45pm, Thursday, 22'nd Feb 2024
In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $51.91, denoting a +1.29% change from the preceding trading day.
Wall Street Bulls Look Optimistic About Amphastar (AMPH): Should You Buy?
10:30am, Thursday, 22'nd Feb 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
04:01pm, Tuesday, 20'th Feb 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / February 20, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2023 ended December 31,
It May Be Time To Revisit Amphastar Once It Settles After A Plunge
08:00am, Friday, 16'th Feb 2024
Drug stock Amphastar Pharmaceuticals took a nasty drop in January after nearing highs. It may time to take another look as earnings approach.
Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why
06:46pm, Friday, 09'th Feb 2024
In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $55.61, denoting a +1.85% change from the preceding trading day.
3 Once-in-a-Lifetime Biotech Stocks With Unprecedented Surge Potential
12:41pm, Monday, 05'th Feb 2024
The biotech sector is one of my favorite sectors since it is not only constantly growing and with companies that are always doing wonderful research, products, and solutions, but it is also a sector t
Amphastar Pharmaceuticals (AMPH) Falls More Steeply Than Broader Market: What Investors Need to Know
06:56pm, Tuesday, 30'th Jan 2024
In the most recent trading session, Amphastar Pharmaceuticals (AMPH) closed at $54.94, indicating a -0.81% shift from the previous trading day.
5 Top Growth Stocks to Buy as Recession Fears Subside
09:25am, Friday, 26'th Jan 2024
Invest in growth stocks such as Amphastar Pharmaceuticals (AMPH), Abercrombie & Fitch (ANF), Cameco (CCJ), CyberArk Software (CYBR) and LendingTree (TREE) as the U.S. economy defies recession fears.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
11:36am, Thursday, 25'th Jan 2024
With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY and TEVA.
Snap these 4 Top-Ranked Liquid Stocks to Drive Solid Returns
08:16am, Monday, 15'th Jan 2024
Here are four top-performing liquid stocks, American Public Education (APEI), Amphastar Pharmaceuticals (AMPH), GigaCloud (GCT) and Oceaneering International (OII), which investors can add to their po
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
07:34pm, Thursday, 11'th Jan 2024
Amphastar Pharmaceuticals (AMPH) concluded the recent trading session at $54.03, signifying a -1.44% move from its prior day's close.
